8-K/A - BioCryst Pharmaceuticals Inc | Modeledge

BioCryst Pharmaceuticals Inc

Filing type: 8-K/A
Filing date: Aug 3, 2026
Updated: Aug 4, 2026 · 5:01 AM

Filing

8-K/AAmended material disclosure